Tandem Diabetes Care, Inc. (TNDM) — Stock Score Summary

Tandem Diabetes Care, Inc. (TNDM) has a MoatMap StockRank of 38/100 based on Quality (40/100), Value (42/100), and Momentum (44/100) factor scores. The current signal is HOLD. Tandem operates in a highly competitive medical device market against deep-pocketed players like Medtronic and Insulet. Lacks the clear, wide economic moat required for our concentrated book.

Tandem Diabetes Care, Inc. is a medical device company focused on improving the lives of people with diabetes through innovative insulin pump technology. The company's t:slim X2 insulin pump with Control-IQ technology offers advanced automated insulin delivery, providing a significant competitive advantage in the personal diabetes management market. Its user-centric design and continuous innovation drive its market penetration and brand loyalty.

Key Financial Metrics

Price$17.61
Market Cap$1.1B
P/E (Forward)331.12
Price/Book8.56
Return on Equity-65.7%
Return on Invested Capital-30.4%
Debt/Equity554.92
Gross Margin54.9%
Operating Margin-7.1%
Revenue Growth5.5%
Free Cash Flow$-20M

Tandem Diabetes Care, Inc. operates in the Medical Devices industry, part of the Healthcare sector (United States).

Frequently Asked Questions

What is Tandem Diabetes Care, Inc.’s (TNDM) StockRank?
MoatMap’s StockRank for Tandem Diabetes Care, Inc. (TNDM) is 38/100, with a Hold signal. It is a composite of Quality (40), Value (42), and Momentum (44) factor ranks across MoatMap’s 19,000+ stock universe.
Does Tandem Diabetes Care, Inc. have an economic moat?
Tandem Diabetes Care, Inc. (TNDM) has a Quality factor score of 40/100. The Quality factor combines ROIC, Piotroski F-Score, and leverage — the financial fingerprints of a durable competitive advantage. A Quality score above 70 typically indicates a company with the characteristics of a moated business.
Is Tandem Diabetes Care, Inc. a buy, hold, or sell?
MoatMap’s current signal for Tandem Diabetes Care, Inc. (TNDM) is Hold, based on a StockRank of 38/100. Signals are derived mechanically from the StockRank composite and should be one input among many — combine with your own thesis on management, competitive position, and valuation.
What sector is Tandem Diabetes Care, Inc. in?
Tandem Diabetes Care, Inc. (TNDM) operates in the Healthcare sector, specifically the Medical Devices industry (United States).
Browse all ranked stocksTNDM deep dive reportAI ChampionsHow we score stocksSense-check another stock